T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Wolverine World Wide
WWW
$1.47B
| $233M | 0.05% |
8,940,130
+3,554,460
| +66% | +$94.6M |
|
402
Loews
L
$23.2B
| $231M | 0.05% |
5,252,516
-806,510
| -13% | -$35.2M |
|
|
BHI
403
DELISTED
Baker Hughes
BHI
| $231M | 0.05% |
3,103,035
-268,923
| -8% | -$18.7M |
|
|
AAN.A
404
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $231M | 0.05% |
6,480,274
+4,700
| +0.1% | +$168K |
|
405
TE Connectivity
TEL
$61.8B
| $231M | 0.05% |
3,731,103
-770,931
| -17% | -$46.2M |
|
406
Texas Capital Bancshares
TCBI
$4.38B
| $229M | 0.05% |
4,237,240
+13,070
| +0.3% | +$733K |
|
|
CMCSK
407
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $228M | 0.05% |
4,274,069
+69,591
| +2% | +$3.71M |
|
408
Shutterstock
SSTK
$202M
| $227M | 0.05% |
2,729,747
+1,667,572
| +157% | +$121M |
|
409
Barclays
BCS
$94.5B
| $225M | 0.05% |
16,656,133
-3,416,503
| -17% | -$51.7M |
|
|
NATI
410
DELISTED
National Instruments Corp
NATI
| $224M | 0.05% |
6,917,720
+176,940
| +3% | +$5.09M |
|
411
Seagate
STX
$200B
| $224M | 0.05% |
3,939,727
+1,197,083
| +44% | +$64.5M |
|
|
CTXS
412
DELISTED
Citrix Systems Inc
CTXS
| $219M | 0.05% |
4,403,999
-1,240,056
| -22% | -$59.6M |
|
|
PFPT
413
DELISTED
Proofpoint, Inc.
PFPT
| $219M | 0.05% |
5,852,997
+2,331,615
| +66% | +$74.5M |
|
414
Enviri
NVRI
$556M
| $218M | 0.05% |
8,182,135
-387,359
| -5% | -$9.9M |
|
|
QUOT
415
DELISTED
Quotient Technology Inc
QUOT
| $218M | 0.05% |
8,638,860
+283,631
| +3% | +$6.32M |
|
416
Graco
GGG
$13.3B
| $217M | 0.05% |
8,328,972
+2,021,364
| +32% | +$49.9M |
|
|
RTN
417
DELISTED
Raytheon Company
RTN
| $214M | 0.05% |
2,323,123
-93,424
| -4% | -$9.06M |
|
|
WCN
418
Waste Connections
WCN
$42B
| $214M | 0.05% |
6,605,867
-3,320,367
| -33% | -$99.8M |
|
419
Lennox International
LII
$14.7B
| $213M | 0.05% |
2,377,890
-416,720
| -15% | -$36.2M |
|
420
Toro Company
TTC
$9.31B
| $213M | 0.05% |
6,682,460
+274,840
| +4% | +$8.76M |
|
|
ABCO
421
DELISTED
Advisory Board Co
ABCO
| $212M | 0.05% |
4,090,984
-589,201
| -13% | -$31.9M |
|
422
Puma Biotechnology
PBYI
$455M
| $212M | 0.05% |
3,210,367
+255,119
| +9% | +$18.1M |
|
|
NBIS
423
Nebius Group N.V.
NBIS
$62.6B
| $211M | 0.05% |
5,909,653
+674,458
| +13% | +$20.7M |
|
|
SAPE
424
DELISTED
SAPIENT CORP
SAPE
| $209M | 0.05% |
12,885,781
+218,030
| +2% | +$3.58M |
|
425
CNA Financial
CNA
$13.7B
| $209M | 0.05% |
5,170,364
+511,032
| +11% | +$20.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.